
Reset all filters
01 2Skyclarys
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 56
2022 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Rare Diseases and Disorders
Currency : USD
2024 Revenue in Millions : 383
2023 Revenue in Millions : 56
Growth (%) : 584